These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 20017071)

  • 1. Association between paraoxonase activity and late saphenous vein graft occlusion in patients with coronary artery bypass grafting.
    Cagirci G; Cay S; Karakurt O; Yazihan N; Aydin C; Acikel S; Dogan M; Kilic H; Topaloglu S; Aras D; Akdemir R
    Kardiol Pol; 2009 Oct; 67(10):1063-8. PubMed ID: 20017071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between plasma asymmetrical dimethylarginine activity and saphenous vein graft disease in patients with coronary bypass.
    Cagirci G; Cay S; Karakurt O; Buyukterzi Z; Yazihan N; Kilic H; Topaloglu S; Aras D; Akdemir R
    Coron Artery Dis; 2010 Jan; 21(1):20-5. PubMed ID: 19996737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance.
    Yilmaz MB; Balbay Y; Caldir V; Ayaz S; Guray Y; Guray U; Korkmaz S
    Thromb Res; 2005; 115(1-2):25-9. PubMed ID: 15567449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adropin: a new marker for predicting late saphenous vein graft disease after coronary artery bypass grafting.
    Demircelik B; Cakmak M; Nazli Y; Gurel OM; Akkaya N; Cetin M; Cetin Z; Selcoki Y; Kurtul A; Eryonucu B
    Clin Invest Med; 2014 Oct; 37(5):E338-44. PubMed ID: 25282140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Do laboratory tests allow prediction of coronary vein bypass patency?].
    Hirnle T
    Kardiol Pol; 2009 Oct; 67(10):1069. PubMed ID: 20209673
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship between saphenous coronary bypass graft occlusion and serum gamma-glutamyltransferase activity.
    Demirkan B; Güray Y; Güray Ü; Turak O; Hajro E; Korkmaz S
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):321-6. PubMed ID: 21200101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of saphenous vein graft hyperplasia and occlusion 1 year after coronary artery bypass grafting: analysis from the CASCADE randomized trial.
    Une D; Kulik A; Voisine P; Le May M; Ruel M
    Circulation; 2013 Sep; 128(11 Suppl 1):S213-8. PubMed ID: 24030409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative neutrophil-lymphocyte ratio and saphenous vein graft patency after coronary artery bypass grafting.
    Taşoğlu I; Turak O; Nazli Y; Ozcan F; Colak N; Sahin S; Kavasoglu K; Genc B; Sert D; Karahan M; Cicek O; Ecevit A
    Clin Appl Thromb Hemost; 2014 Nov; 20(8):819-24. PubMed ID: 23580624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries.
    Lytle BW; Loop FD; Taylor PC; Goormastic M; Stewart RW; Novoa R; McCarthy P; Cosgrove DM
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):605-12; discussion 612-4. PubMed ID: 8468995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial grafts do not counteract target vessel occlusion.
    Bartnes K; Hermansen SE; Dahl-Eriksen Ø; Bahar R; Busund R; Sørlie DG; Myrmel T
    Eur J Cardiothorac Surg; 2013 Nov; 44(5):e320-4. PubMed ID: 23956270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events?
    Hedman A; Larsson PT; Alam M; Wallen NH; Nordlander R; Samad BA
    Int J Cardiol; 2007 Aug; 120(1):108-14. PubMed ID: 17141340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts.
    Khot UN; Friedman DT; Pettersson G; Smedira NG; Li J; Ellis SG
    Circulation; 2004 May; 109(17):2086-91. PubMed ID: 15123539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of saphenous vein graft versus right gastroepiploic artery to revascularize the right coronary artery: a prospective randomized clinical, functional, and angiographic midterm evaluation.
    Glineur D; Hanet C; Poncelet A; D'hoore W; Funken JC; Rubay J; Astarci P; Lacroix V; Verhelst R; Etienne PY; Noirhomme P; El Khoury G
    J Thorac Cardiovasc Surg; 2008 Aug; 136(2):482-8. PubMed ID: 18692661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The no-touch saphenous vein as the preferred second conduit for coronary artery bypass grafting.
    Dreifaldt M; Mannion JD; Bodin L; Olsson H; Zagozdzon L; Souza D
    Ann Thorac Surg; 2013 Jul; 96(1):105-11. PubMed ID: 23684156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safe approach for redo coronary artery bypass grafting--preventing injury to the patent graft to the left anterior descending artery.
    Nishi H; Mitsuno M; Yamamura M; Tanaka H; Ryomoto M; Fukui S; Yoshioka Y; Takanashi S; Miyamoto Y
    Ann Thorac Cardiovasc Surg; 2010 Aug; 16(4):253-8. PubMed ID: 21057442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting.
    Moor E; Silveira A; van't Hooft F; Tornvall P; Blombäck M; Wiman B; Rydén L; Hamsten A
    Thromb Haemost; 1998 Aug; 80(2):220-4. PubMed ID: 9716141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late outcomes after radial artery versus saphenous vein grafting during reoperative coronary artery bypass surgery.
    Zacharias A; Schwann TA; Riordan CJ; Durham SJ; Shah AS; Engoren M; Habib RH
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1511-1518.e4. PubMed ID: 19818456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional flow reserve-guided coronary artery bypass grafting: can intraoperative physiologic imaging guide decision making?
    Ferguson TB; Chen C; Babb JD; Efird JT; Daggubati R; Cahill JM
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):824-835.e1. PubMed ID: 23915918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum gamma-glutamyltransferase activity: a new marker for coronary artery bypass graft disease].
    Ulus T; Yıldırır A; Sade LE; Balta S; Ozin B; Sezgin A; Müderrisoğlu H
    Turk Kardiyol Dern Ars; 2011 Apr; 39(3):205-13. PubMed ID: 21532296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.